4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001209191-20-005167
Director bought 7,500,000 shares at $0.67 ($5,000,250)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Behbahani Ali Director | 2020-01-24 | Purchase | +7,500,000 | $0.67 | $5,000,250 | 19,500,000 | I |
| Open-market purchases · 7,500,000 sh · avg $0.67 · $5,000,250 | |||||||
Loading xslF345X03/doc4.xml…